Divisas / MESO
MESO: Mesoblast Limited - American Depositary Shares
11.11
USD
0.11
(1.00%)
El tipo de cambio de MESO de hoy ha cambiado un 1.00%. En este caso, el precio mínimo en el mercado ha alcanzado 10.80, mientras que el máximo ha alcanzado 11.22.
Siga la dinámica de la pareja de divisas Mesoblast Limited - American Depositary Shares. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
MESO News
- Seeking Alpha Mesoblast: A Cautionary Hold On Regenerative Medicine's Risky Edge (Upgrade)
- Benzinga Centene, BrightView Holdings, ArriVent BioPharma And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - BrightView Hldgs (NYSE:BV), ArriVent BioPharma (NASDAQ:AVBP)
- Benzinga Why Greenbrier Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - Argo Blockchain (NASDAQ:ARBK)
- Benzinga Mesoblast, Atai Life Sciences, Melco Resorts & Entertainment And Other Big Stocks Moving Higher On Tuesday - Advance Auto Parts (NYSE:AAP), ATAI Life Sciences (NASDAQ:ATAI)
- Benzinga Mesoblast Targets Accelerated FDA Approval For Heart Failure Drug Revascor - Mesoblast (NASDAQ:MESO)
- Benzinga Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Aptevo Therapeutics (NASDAQ:APVO), AIRO Group Holdings (NASDAQ:AIRO)
- Benzinga Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket - Aptevo Therapeutics (NASDAQ:APVO), Arqit Quantum (NASDAQ:ARQQ)
- Investing Mesoblast Maintains Momentum With FDA on Accelerated Approval Pathway for Revascor ® in Ischemic Heart Failure and Label Extension for Ryoncil ® in Adults With GvHD
- Investing FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil ®
- Benzinga Booz Allen Hamilton, Movado Group And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Booz Allen Hamilton (NYSE:BAH), Betterware de Mexico SAPI (NYSE:BWMX)
- Seeking Alpha Syndax Pharmaceuticals: Down But Not Out (NASDAQ:SNDX)
- Seeking Alpha Mesoblast Limited 2024 Q4 - Results - Earnings Call Presentation (NASDAQ:MESO)
- Seeking Alpha Mesoblast: Ryoncil Approval Overshadowed By Commercial Hurdles (NASDAQ:MESO)
Rango diario
10.80
11.22
Rango anual
5.78
22.00
- Cierres anteriores
- 11.02
- Open
- 11.00
- Bid
- 11.11
- Ask
- 11.41
- Low
- 10.80
- High
- 11.22
- Volumen
- 447
- Cambio diario
- 1.00%
- Cambio mensual
- -7.42%
- Cambio a 6 meses
- -43.00%
- Cambio anual
- 65.82%
12 julio, sábado